Significant transformations are undergoing in the Clinical chemistry markets due to stringent regulations and advancements in diagnostic technologies, system engineering, automation, and IT technology. Also due to an increase in infectious and lifestyle diseases, such as diabetes and cardiovascular disorders, there is a prediction for significant growth in the global clinical chemistry market. Thus, current technologies have sanctioned a better perception of disease procedures. The International Diabetes Federation states that by 2040 more than 10% of the world’s adult population or around 642 million people will have diabetes. Also, the growth in the aging population is raising the clinical chemistry market as elderly people are generally prone to infectious diseases and other disorders. A peak in the use of automation in health care and developments in health care infrastructure is expected to create opportunities for the clinical chemistry market.